1% topical cidofovir used as last alternative to treat viral infections.
Briand
S
S
Milpied
B
B
Navas
D
D
Thomare
P
P
Stalder
J F
JF
D017088:AIDS-Related Opportunistic Infections / Q000150:complications; D000287:Administration, Topical; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008976:Molluscum Contagiosum / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D063065:Organophosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
D000998:Antiviral Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir